Manhattan Associates Inc (MANH) Receives Overweight Rating from Barclays

2 min readBy Investing Point

Barclays has initiated coverage on Manhattan Associates Inc (MANH) with an Overweight rating, marking the firm's first assessment of the company. This rating reflects Barclays' analysis of Manhattan Associates' business, industry dynamics, and growth prospects.

Headquartered in Atlanta, Georgia, Manhattan Associates develops software solutions aimed at managing supply chains, inventory, and omnichannel operations for various sectors, including retail and logistics. The company has a market capitalisation of $10.3 billion, with a trailing P/E ratio of 47.84 and an earnings per share (EPS) of 3.52.

Manhattan Associates is set to announce its next earnings on July 20, 2026, with analysts estimating an EPS of $1.41 and revenue of $294.0 million. Recent performance has shown strong results, with Q3 2025 EPS reported at $1.36, exceeding expectations by 13.4%.

Analyst ratings and price targets are derived from research and financial models, providing insight into market perceptions. However, such assessments are based on assumptions that may not always materialise. Investors are encouraged to consider a range of factors, including company fundamentals and industry trends, when making decisions. Analyst views should be one of many inputs rather than the sole basis for investment choices. It is also important to note that analyst ratings can evolve as new information becomes available.

As of November 1, 2025, the consensus among analysts is a Buy, with 6 Strong Buy, 8 Buy, and 5 Hold ratings. Recent actions include Stifel initiating coverage with a Buy rating on October 8, 2025, alongside Barclays' initiation on the same day.

This brief was generated from structured financial data and reviewed by the Investing Point editorial team. It is for informational purposes only and does not constitute investment advice. Market data provided by Finnhub.

Related Stocks

More in this Category

Analyst Ratings

Explore more analyst ratings or view detailed analysis for MANH stock.